Home > Insider Trading > Filing (0001012975-20-000407)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1211583	Fennec Pharmaceuticals Inc.	FENC	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1319998	Southpoint Capital Advisors Lp	1114 Avenue Of The Americas, 22Nd Floor New York NY 10036	No	No	Yes	No
1378376	Southpoint Gp, Lp	1114 Avenue Of The Americas, 22Nd Floor New York NY 10036	No	No	Yes	No
1378377	Southpoint Capital Advisors Llc	1114 Avenue Of The Americas, 22Nd Floor New York NY 10036	No	No	Yes	No
1378378	Southpoint Gp, Llc	1114 Avenue Of The Americas, 22Nd Floor New York NY 10036	No	No	Yes	No
1378379	Ii Smith John Clark	1114 Avenue Of The Americas, 22Nd Floor New York NY 10036	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-05-04	80,000	$6.25	4,077,214	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote

Footnotes

The securities are directly held by Southpoint Master Fund, LP for which Southpoint Capital Advisors LP serves as the investment manager and Southpoint GP, LP serves as the general partner. Southpoint Capital Advisors LLC serves as the general partner of Southpoint Capital Advisors LP and Southpoint GP, LLC serves as the general partner of Southpoint GP, LP. John S. Clark II serves as managing member of both Southpoint Capital Advisors LLC and Southpoint GP, LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest therein.